Venezuela (Bolivarian Republic of)
Tuberculosis profile
Population  2012 30 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.73 (0.42–1.1) 2.4 (1.4–3.8)
Mortality (HIV+TB only) 0.33 (<0.01–1.2) 1.1 (0.03–4.1)
Prevalence  (includes HIV+TB) 15 (7.6–26) 52 (25–87)
Incidence  (includes HIV+TB) 9.9 (8.2–12) 33 (27–39)
Incidence (HIV+TB only) 1.2 (0.94–1.4) 3.9 (3.1–4.7)
Case detection, all forms (%) 65 (55–79)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 3 446 (56) Relapse 289 (51)
Smear-negative 1 443 (23) Treatment after failure 6 (1)
Smear-unknown / not done 174 (3) Treatment after default 189 (33)
Extrapulmonary 1 143 (18) Other 87 (15)
Other 0 (0)      
Total new 6 206   Total retreatment 571  
           
Other (history unknown) 0        
Total new and relapse 6 495   Total cases notified 6 777  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6 1.2 1.3
Age < 15 55 309 140
Laboratories 2012
Smear (per 100 000 population) 0.8
Culture (per 5 million population) 3.5
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 80   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 81  
Retreatment 80  
TB/HIV 2012 Number (%)
TB patients with known HIV status 4 956 (73)
HIV-positive TB patients 581 (12)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 517 (89)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.52 (0.14–1.3) 13 (7.6–22)
MDR-TB cases among notified pulmonary
TB cases
26 (7–67) 77 (43–120)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 460 (13%) 148 (26%) 614
Laboratory-confirmed MDR-TB cases 1 20 21
Patients started on MDR-TB treatment     21
Financing TB control 2013
National TB programme budget (US$ millions) 1.7
% Funded domestically 100%
% Funded internationally 0%
% Unfunded <1%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data